Moderna

Moderna weekly uptrend opportunity based On 1.00 Lot Calculation:

• Moderna, Inc. a clinical stage biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, and cardiovascular diseases.
• EVENT: (Earning report Thursday, February 25, aftermarket); Moderna is expected to report a loss per share of $0.36, which is a smaller loss by 33% compared to the prior-year quarter. Revenue is estimated to be around $280 million, or more than 20 times higher than the prior-year quarter.
• Yesterday, Moderna announced that the European Commission purchased an additional 150 million doses of its COVID-19 vaccine, to be delivered in the third and fourth quarter of 2021. This brings Europe’s total order to 310 million doses of for delivery in 2021.
• Moderna is on track to make 600 million doses of its coronavirus vaccine this year, Moderna CEO Stephane Bancel said. The company is now adding staff with the hopes of reaching 1 billion doses this year and up to 1.2 billion doses in 2022. This is key because Covid-19 is here to stay, Bancel predicted.
• Moderna stock posted a 66% gain in January as its coronavirus vaccine gained authorizations in a wide swath of countries, including the United States.

Moderna, February 18, 2021
Current Price: 174

Example of calculation based on weekly trend direction for 1.00 Lot*

* 1.00 lot is equivalent of 1000 units
** Calculations for exchange rate used as of 14:30 am GMT 18/02/2021
Fortrade recommends the use of Stop-Loss and Take-Profit, please speak to your Client Manager regarding their use.
*** You may wish to consider closing your position in profit, even if it is lower than suggested one
**** Trailing stop technique can protect the profit – Ask your Client Manager for more detail